2171 ⎘
Modified animals Animals modified by protein administration, for non-therapeutic purpose
CRISPR HAVING OR ASSOCIATED WITH DESTABILIZATION DOMAINS
#2METHOD FOR PRODUCING NONHUMAN PRIMATE ANIMAL MODEL OF CEREBRAL INFARCTION AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CEREBRAL INFARCTION
#3METHOD FOR CONSTRUCTING AN ANIMAL MODEL OF OPEN-ANGLE GLAUCOMA
#4COMPOSITION
#5TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#6Multiplexed Genome Editing
#7MAP44 POLYPEPTIDES AND CONSTRUCTS BASED ON NATURAL ANTIBODIES AND USES THEREOF
#8ANIMAL MODELS, SCREENING METHODS, AND TREATMENT METHODS FOR INTRAOCULAR DISEASES OR DISORDERS
#9SIMPLE AND RAPID CONSTRUCTION OF RAT MODEL OF CONSTIPATION AND USE THEREOF
#10METHOD FOR CONSTRUCTING MODEL OF VITILIGO AND THE USE OF THE MODEL
#11Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis (ALS) by UPF2
#12ANIMAL MODEL FOR NEURODEGENERATIVE DISORDERS
#13METHODS OF PRODUCING GRANULOMAS AND ANIMAL MODELS OF SARCOIDOSIS
#14Animal models, screening methods, and treatment methods for intraocular diseases or disorders
#15PATIENT-DERIVED AMYLOID XENOGRAFT NON-HUMAN ANIMAL MODEL
#16Rat model of IgA nephropathy induced with a multimeric recombinant IgA fragment
#17CRISPR HAVING OR ASSOCIATED WITH DESTABILIZATION DOMAINS
#18Method for producing recombinant proteins in insects
#19Anti-polyethylene glycol (PEG) antibody mouse model for rigorous assessment of PEG-based therapies
#20Multiplexed genome editing
#21Method for preparing non-human primate somatic cell cloned animal
#22PRODUCTS AND METHODS ASSOCIATED WITH MULTIPLE SCLEROSIS AS A TRANSMISSIBLE PROTEIN MISFOLDING DISORDER
#23Multiplexed genome editing
#24Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF1
#25Recombinant HIV compositions and uses thereof in animal models
#26Methods for autocatalytic genome editing and neutralizing autocatalytic genome editing and compositions thereof
#27MOUSE MODEL OF RETINAL DEGENERATION
#28Development of YY male fish broodstocks in a single generation
#29Multiplexed genome editing
#30Mouse Models Having a Knockin Scavenger Receptor Class B Type I
#31MOUSE MODEL OF RETINAL DEGENERATION
#32HUMANIZED MOUSE MODEL
#33Multiplexed genome editing
#34GENERATION OF HUMAN MACROPHAGES IN IMMUNODEFICIENT NON-HUMAN HOSTS
#35MOUSE MODEL OF RETINAL DEGENERATION
#36CRISPR HAVING OR ASSOCIATED WITH DESTABILIZATION DOMAINS
#37ANIMAL MODEL OF NEURONAL INJURY
#38Method for Preventing or Treating a Protein Aggregation Disease
#39MOUSE MODEL OF RETINAL DEGENERATION
#40VH4 ANTIBODIES AGAINST GRAY MATTER NEURON AND ASTROCYTE
#41Animal models for evaluating pharmaceutical compounds
#42MOUSE MODEL OF RETINAL DEGENERATION
#43Methods of identifying compounds for the treatment of fibrosis by using S1PR5
#44Animal model of neuronal injury
#45Methods of reducing TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis by a UPF1 polypeptide or polynucleotide
#46Long term disease modification using immunostimulatory oligonucleotides
#47Compositions And Methods Of Inhibiting NADPH Oxidase Expression
#48Conjugates comprising mannan and myelin oligodentrocyte glycoprotein (MOG)
#49METHODS FOR PRODUCING FISH WITH HIGH LIPID CONTENT
#50Long term disease modification using immunostimulatory oligonucleotides
#51CYP46A1 gene for the treatment of alzheimer's disease
#52ANIMAL MODEL FOR HIV INDUCED DISEASE
#53Infected nail of animal infected with fungus
#54COMPOSITIONS AND METHODS FOR INHIBITING NADPH OXIDASE EXPRESSION
#55Methods for producing a non human model for aortic aneurysm
#56Osteopenia animal model
#57COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY IN THE MOUSE
#58Methods for rescuing learning and/or memory deficits caused by alzheimer's disease by G-CSF
#59Mouse model of retinal degeneration
#60Articular cartilage gene therapy with recombinant vector encoding BMP-7
#61DNA vaccine
#62VASOACTIVE INTESTINAL POLYPEPTIDE COMPOSITIONS
#63Method for treating asthma and chronic obstructive pulmonary disease (COPD) comprising administering FGF2
#64METHODS OF INDUCING AND TREATING VASCULAR DISEASE
#65Animal model for HIV induced disease
#66Animal model for schizophrenia